China Radiation Oncology Market Size & Outlook, 2020-2028
China radiation oncology market, 2017-2028 (US$M)
Related Markets
China radiation oncology market highlights
- The China radiation oncology market generated a revenue of USD 296.3 million in 2020 and is expected to reach USD 544.7 million by 2028.
- The China market is expected to grow at a CAGR of 7.9% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 296.3 million |
| Market revenue in 2028 | USD 544.7 million |
| Growth rate | 7.9% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, China accounted for 3.9% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 532.9 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 76.17% in 2020. Horizon Databook has segmented the China radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
China radiation oncology market exhibits one of the highest market share in Asia Pacific, owing to factors such as introduction of new technologies and presence of large target population. In addition, rising number of collaborations and partnerships among organizations is expected to drive the radiation oncology market in this country.
In December 2019, Icon Group announced the distribution of Varian Halcyon System to Jiangxian Red Cross Hospital. Moreover, in January 2020, Guangzhou Qixi Group Co., Ltd. purchased Monaco treatment planning, MOSAIQ Oncology Information System, five Elekta Synergy systems, and five Elekta Infinity systems to address unmet needs.
Announced the launch of Elekta Radiation Therapy Academy in January 2019. This academy will support the development of the country’s radiotherapy industry and provide training to radiotherapy professionals. Furthermore, in 2017, iCAD, a New Hampshire medical device manufacturer.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China radiation oncology market size, by type, 2017-2028 (US$M)
China Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
